Antiscience in the United States: Historical Frameworks and Current Threats to Biomedicine
Faculty and trainees within the Department of Medicine who are involved in the care of patients need to receive regular updates on recent advances and guidelines in the field of internal medicine. Clinical scenarios will be used to review the current management of common medical conditions, including chronic pain and opioid abuse. Multidisciplinary sessions will be also used to educate learners about human trafficking and the role of physicians in identifying and assisting victims in the community. The overall aim of the series is to advance clinical knowledge, enhance the quality of patient care, and improve treatment outcomes.
Physicians, medical students, fellows, and residents.
At the conclusion of the session, the participants should be able to:
Summarize the impact of neglected tropical diseases and COVID-19 among unvaccinated populations in the United States and globally.
Recognize global failures or weaknesses in vaccinating the populations of low-income and middle-income countries, especially in Latin America, Southeast Asia, and Africa.
Review the experience with the Texas Children’s Hospital recombinant protein vaccine now in use in India where it is known as Corbevax.
Discuss the origins of rising antiscience sentiments in the United States and their recent shift to an antivaccination focus.
Promote strategies to counter antiscience activities, especially related to vaccination misinformation.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Ethics
- 1.00 Participation